association id |
FEATURE |
Drug id |
Propr |
Public |
Drug Name |
Drug Target |
N FEATURE pos |
N FEATURE neg |
log max Conc tested |
FEATURE neg logIC50 MEAN |
FEATURE pos logIC50 MEAN |
FEATURE deltaMEAN IC50 |
FEATURE IC50 effectSize |
FEATURE neg Glass delta |
FEATURE pos Glass delta |
ANOVA FEATURE pval |
Tissue ANOVA pval |
MSI ANOVA pval |
ANOVA FEATURE FDR % |
a42 |
EWSR1-FLI1_mut |
257 |
1 |
1 |
NPK76-II-72-1 |
PLK3 |
17 |
902 |
2.33 |
2.89 |
0.917 |
-1.98 |
1.2 * |
1.2 * |
1.6 * |
8.15e-08 |
1.57e-76 |
3.64e-02 |
0.032 |
a190 |
MLL2_mut |
257 |
1 |
1 |
NPK76-II-72-1 |
PLK3 |
96 |
823 |
2.33 |
2.97 |
1.92 |
-1.05 |
0.62 . |
0.62 . |
0.6 . |
7.25e-05 |
1.73e-75 |
3.78e-02 |
6.3 |
a281 |
gain_cnaPANCAN365 |
257 |
1 |
1 |
NPK76-II-72-1 |
PLK3 |
63 |
856 |
2.33 |
2.78 |
3.96 |
1.18 |
0.7 . |
0.69 . |
0.91 . |
2.02e-04 |
2.47e-75 |
3.8e-02 |
12 |
a376 |
gain_cnaPANCAN366 |
257 |
1 |
1 |
NPK76-II-72-1 |
PLK3 |
81 |
838 |
2.33 |
2.76 |
3.84 |
1.08 |
0.64 . |
0.63 . |
0.8 . |
3.84e-04 |
3.07e-75 |
3.81e-02 |
17 |
a380 |
gain_cnaPANCAN364_(STK4) |
257 |
1 |
1 |
NPK76-II-72-1 |
PLK3 |
70 |
849 |
2.33 |
2.77 |
3.88 |
1.1 |
0.65 . |
0.64 . |
0.85 . |
3.95e-04 |
3.1e-75 |
3.81e-02 |
17 |
a403 |
gain_cnaPANCAN367_(ARFGAP1,GNAS) |
257 |
1 |
1 |
NPK76-II-72-1 |
PLK3 |
116 |
803 |
2.33 |
2.74 |
3.66 |
0.921 |
0.54 . |
0.53 . |
0.66 . |
4.78e-04 |
3.31e-75 |
3.82e-02 |
20 |